A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine)

Clinical trial NCT05072080 · COMPLETED

Trial details

NCT number: NCT05072080
Sponsor: Bavarian Nordic
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chikungunya Virus

Start date: 2021-09-29
Primary completion: 2023-04-03
Enrollment: 3258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.